Literature DB >> 23800457

Modulation of multiple sclerosis by sunlight exposure: role of cis-urocanic acid.

Jorge Correale1, Mauricio F Farez.   

Abstract

The role of cis-urocanic acid (UCA) as a UV-mediated immunomodulator in MS patients was investigated. Plasma levels of cis-UCA were significantly lower in MS patients compared to controls. Stimulation of MBP- and MOG-specific T cells in the presence of cis-UCA, significantly increased IL-10, and inhibited IFN-γ production. PBMCs cultured in the presence of cis-UCA increased CD4(+)CD25(+)FoxP3(+) regulatory T cell percentages. Dendritic cells cultured in the presence of cis-UCA significantly reduced Ag presentation capacity. Finally, cis-UCA activated the 5-HT2A receptor, inducing the increase in phosphorylated forms of ERK 1/2 and JNK2. Thus, in addition to vitamin D, cis-UCA also appears to be an additional UV-mediated immunomodulator.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytokines; Environmental factors; Multiple sclerosis; Ultraviolet radiation; Urocanic acid

Mesh:

Substances:

Year:  2013        PMID: 23800457     DOI: 10.1016/j.jneuroim.2013.05.014

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

Review 1.  Lifestyle and Environmental Factors in Multiple Sclerosis.

Authors:  Lars Alfredsson; Tomas Olsson
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

Review 2.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.

Authors:  Tomas Olsson; Lisa F Barcellos; Lars Alfredsson
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

Review 3.  Prevention of Photocarcinogenesis by Agonists of 5-HT1A and Antagonists of 5-HT2A Receptors.

Authors:  Ana Catarina Menezes; Sara Raposo; Sandra Simões; Helena Ribeiro; Helena Oliveira; Andreia Ascenso
Journal:  Mol Neurobiol       Date:  2015-01-15       Impact factor: 5.590

Review 4.  Are there differences in immune responses following delivery of vaccines through acutely or chronically sun-exposed compared with sun-unexposed skin?

Authors:  Prue H Hart; Mary Norval
Journal:  Immunology       Date:  2019-11-06       Impact factor: 7.397

5.  PRKCZ methylation is associated with sunlight exposure in a North American but not a Mediterranean population.

Authors:  Stella Aslibekyan; Hassan S Dashti; Toshiko Tanaka; Jin Sha; Luigi Ferrucci; Degui Zhi; Stefania Bandinelli; Ingrid B Borecki; Devin M Absher; Donna K Arnett; Jose M Ordovas
Journal:  Chronobiol Int       Date:  2014-07-30       Impact factor: 2.877

6.  Suppression of experimental autoimmune encephalomyelitis by ultraviolet light is not mediated by isomerization of urocanic acid.

Authors:  Amy A Irving; Steven J Marling; Lori A Plum; Hector F DeLuca
Journal:  BMC Neurosci       Date:  2017-01-05       Impact factor: 3.288

7.  Environmental factors influencing multiple sclerosis in Latin America.

Authors:  Jorge Correale; Mauricio F Farez; María Inés Gaitán
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-06-13

Review 8.  The risks and benefits of sun exposure 2016.

Authors:  David G Hoel; Marianne Berwick; Frank R de Gruijl; Michael F Holick
Journal:  Dermatoendocrinol       Date:  2016-10-19

9.  Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells.

Authors:  Claire S Leitch; Eenass Natafji; Cunjing Yu; Sharizan Abdul-Ghaffar; Nayani Madarasingha; Zoë C Venables; Roland Chu; Paul M Fitch; Andrew J Muinonen-Martin; Linda E Campbell; W H Irwin McLean; Jürgen Schwarze; Sarah E M Howie; Richard B Weller
Journal:  J Allergy Clin Immunol       Date:  2016-03-02       Impact factor: 10.793

10.  Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate.

Authors:  Karolina Bossak-Ahmad; Marta D Wiśniewska; Wojciech Bal; Simon C Drew; Tomasz Frączyk
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.